The opinions expressed on this site are those of the author and other commenters and are not necessarily those of his employer or any other organisation.
David Kirk runs Milliman’s actuarial consulting practice in Africa.
He is an actuary and is the creator of New Business Margin on Revenue. He specialises in risk and capital management, regulatory change and insurance strategy. He also has extensive experience in embedded value reporting, insurance-related IFRS and share option valuation. He has been involved in significant insurance projects across Sub Saharan Africa and the Middle East.
David began his career at Tillinghast – Towers Perrin working in the London and Cape Town offices, gaining exposure to the insurance markets, products and regulatory environments in South Africa, the UK and Europe.
David then headed up the Johannesburg actuarial practice for PricewaterhouseCoopers as a partner with core responsibilities around life insurance, general insurance, financial and risk management and business development.
Thereafter, David successfully reinvented KPMG’s South African actuarial consulting business as the partner responsible for actuarial work across South Africa. A key piece of work delivered here was the Economic Impact Assessment for the FSB’s Solvency Assessment and Management regulatory reform.
David is a member of ASSA’s Life Assurance Committee and chairs the Micro-insurance Committee. He has lectured parts of undergraduate and postgraduate courses at the University of Cape Town, the University of Stellenbosch and the Lebanese University. He a course creator and lecturer for several ASSA Normative Skills Workshops and contributes to professionalism course for newly qualified actuaries.
David is a Fellow of the Institute of Actuaries (FIA) and a Fellow of the Actuarial Society of South Africa. He holds a B.Bus.Sci degree in actuarial science and finance from the University of Cape Town, is CFA Charterholder, a Chartered Alternative Investment Analyst (CAIA) and a Certified Professional Risk Manager (PRM).